Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02538510 · OUTCOME

Progression Free Survival

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery · Source last updated 2024-11-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
Months
Interval / dispersion
95% Confidence Interval
Time frame
Up to 2 years

What was measured

The Kaplan Meier methods will be used to estimate progression free survival.

Groups in this outcome

Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma patients

Salivary Gland Carcinoma

Salivary Gland Carcinoma patients

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Head and Neck Squamous Cell Carcinoma25
Salivary Gland Carcinoma25

Reported measurements

Source class 1
Values in Months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Head and Neck Squamous Cell Carcinoma12.6Not reported8.115.3Not reported
Salivary Gland Carcinoma14.0Not reported8.524.5Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        8.1
        upper Limit
        15.3
        value
        12.6
      2. group Id
        OG001
        lower Limit
        8.5
        upper Limit
        24.5
        value
        14.0
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    2. group Id
      OG001
      value
      25
    units
    Participants
description
The Kaplan Meier methods will be used to estimate progression free survival.
dispersion Type
95% Confidence Interval
groups
  1. description
    Head and Neck Squamous Cell Carcinoma patients
    id
    OG000
    title
    Head and Neck Squamous Cell Carcinoma
  2. description
    Salivary Gland Carcinoma patients
    id
    OG001
    title
    Salivary Gland Carcinoma
param Type
MEAN
reporting Status
POSTED
time Frame
Up to 2 years
title
Progression Free Survival
type
SECONDARY
unit Of Measure
Months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice